Introduction {#s1}
============

The ubiquitin-proteasome system (UPS) is a major pathway for protein degradation to maintain normal cellular activities \[[@r7]\]. A superfamily of proteins named deubiquitinating enzymes (DUBs) is involved in this process. Ubiquitin C-terminal hydrolases (UCHs) belong to DUBs, and at least four UCHs isozymes, which include UCH-L1, UCH-L3, UCH-L4 and UCH-L5 have been identified in mice. Among these isozymes, the expression and function of UCH-L4 and UCH-L5 are rarely known. On the other hand, mouse UCH-L1 and UCH-L3 share 52% amino acid sequence identity \[[@r15], [@r23], [@r33]\]. UCH-L3 is known to be expressed in almost all types of cells, whereas UCH-L1 was initially isolated from the brain, in which it was regarded as a neuronal marker and functioned as a monoubiquitin stabilizer \[[@r4], [@r22]\]. In regard to its multifunction trait, UCH-L1 has been becoming one of the most dramatic proteins nowadays. There has been a close association of mutations in *Uchl1* gene with neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease \[[@r21], [@r28]\]. In addition, UCH-L1 was also reported to be expressed in a various types of tumor tissues \[[@r3]\].

The anterior pituitary gland is an important component of the hypothalamic-pituitary-gonadal (HPG) axis. It consists of five distinct endocrine hormone-producing cell types, which include adrenocorticotropic hormone (ACTH) in corticotropes, growth hormone (GH) in somatotropes, prolactin (PRL) in lactotropes, thyroid-stimulating hormone (TSH) in thyrotropes and follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in gonadotropes, with a non-hormone producing cell type, the folliculostellate cells (FS cells). It has been reported that UCH-L1 is expressed in the anterior pituitary gland, suggesting particular functions of UCH-L1 in the organ, because UCH-L1 was selectively expressed unlike its isozyme UCH-L3 that was expressed ubiquitously \[[@r12], [@r34]\]. Among the components in the HPG-axis, it has been demonstrated the association of UCH-L1 with monoubiquitin in the neurons, in which UCH-L1 stabilized monoubiquitin, as well as the regulatory function of UCH-L1 in apoptosis in the testicular germ cells \[[@r17], [@r22]\]. Furthermore, a novel role of UCH-L1 in polyspermy block has also been elucidated in mouse ova \[[@r14], [@r27]\]. However, the precise distribution of UCH-L1 in the anterior pituitary gland has not yet been demonstrated in detail.

The gracile axonal dystrophy (*gad*) mouse is an autosomal recessive spontaneous mutant which has an intragenic deletion of the gene encoding mouse UCH-L1 (*Uchl1*). The deletion in *Uchl1* gene results in the systemic lack of the UCH-L1 protein expression \[[@r25]\]. This mouse model has been broadly used to investigate the functional role of UCH-L1 in the nervous and reproductive systems. However, it remains unspecified what kinds of roles the UCH-L1 plays in the anterior pituitary gland in mice.

In the present study, we attempted to determine the specific localization and expression pattern of UCH-L1 in mouse anterior pituitary gland. We found that UCH-L1 was expressed restrictedly in hormone-producing cells, but not non-hormone producing FS cells. Furthermore, the comparative analysis using wild type and UCH-L1-deficient *gad* mice indicated significant decreases in FSH cells, LH cells as well as PRL cells in *gad* mice, suggesting the importance of UCH-L1 in these cells. These data might provide a new insight into the roles of UCH-L1 in the HPG-axis.

Materials and Methods {#s2}
=====================

Animals
-------

ICR male mice were purchased from Nihon SLC Inc. (Hamamatsu, Japan), and acclimated for 1 week. UCH-L1-deficient *gad* mice were obtained from National Institute of Neuroscience, National Center of Neurology and Psychiatry. The *gad* line was maintained by intercrossing for more than 20 generations as CBA and RFM mixed background. These mice were maintained at Department of Biomedical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo. Animal care and handling were in accordance with institutional regulations and were approved by the Animal Care and Use Committee, The University of Tokyo.

Cell cultures and preparation
-----------------------------

αT3-1 and LβT-2 cells were generous gifts from Prof. Pamela Mellon (University of California, San Diego, CA, USA) \[[@r1], [@r24]\]. Both cell lines were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM; Wako Pure Chemical, Ltd., Tokyo, Japan), supplemented with 10% heat-inactivated fetal calf serum, 100 *µ*g/ml penicillin and 100 IU/ml streptomycin at 37°C in a humidified atmosphere of 5% CO~2~ in 95% air. Cells were seeded and cultured in 6-well culture plates (Thermo Scientific, Rochester, NY, USA) or 8-well culture slides of Lab Tek II Chamber (Thermo Scientific) for experiments.

Primary antibodies
------------------

Rabbit polyclonal anti-UCH-L1 antibody was provided by Dr. Kwon (Chonbuk National University, Korea). Rabbit polyclonal anti-PGP 9.5 antibody was obtained from UltraClone (Wight, UK). Mouse monoclonal anti-PGP 9.5 antibody was obtained from Neuromics (Northfield, MN, USA). Rabbit polyclonal anti-UCH-L3 antibody was obtained from Cell Signaling (Beverly, MA, USA). Mouse monoclonal anti-TSH, anti-ACTH, and rabbit polyclonal anti-GH, anti-S-100 antibodies were purchased from Dako (Glostrup, Denmark). Rabbit polyclonal anti-FSH, anti-LH and anti-PRL antibodies were purchased from Biogenisis (Poole, UK). Mouse monoclonal anti-β-actin antibody was from Sigma-Aldrich (St Louis, MO, USA).

Immunohistochemistry
--------------------

Deparaffinized sections (2 *µ*m thickness) were treated with absolute methanol containing 1% H~2~O~2~ for 30 min to block endogenous peroxidase activity. In order to enhance immunoreactivity, sections were subjected to autoclave treatment for 5 min at 100°C. Non-specific binding was blocked by incubation with 100% Block Ace (Dainippon Sumitomo Pharma Ltd., Osaka, Japan) for 1 h at room temperature. Then, the sections were incubated with primary antibodies against UCH-L1, FSH, LH, PRL and GH, respectively. The following day, sections were incubated with either biotinylated goat anti-rabbit or goat anti-mouse IgG antibody (DAKO Co.). After washing with PBS, the sections were incubated with streptavidin-biotin-horseradish peroxidase complex (sABC kit, DAKO Co.). Finally, the immunoreaction was visualized by incubation in 3, 3′-diaminobenzidine tetroxide (Sigma Chemical Co.) and the sections were counterstained with hematoxylin.

Immunofluorescent staining
--------------------------

For immunofluorescent staining of pituitary tissue, experiments were performed in a standard method. Briefly, after antigen retrieval and blocking of non-specific binding, sections were incubated with anti-UCH-L1 and anti-hormone antibody or anti-S-100 antibody for 16 h at 4°C. The following day, Alexa Fluor 488-labeled anti-rabbit IgG and Alexa Fluor 568-labeled anti-mouse IgG antibodies were incubated for 1 h at room temperature. Stained sections were mounted with mounting medium (DAKO). Images were captured with a Zeiss LSM 510 confocal microscope.

For immunofluorescent staining of cultured cells, αT3-1 and LβT-2 cells were seeded in 8-well culture slides 24 h prior to experiment at a density of 1 × 10^4^ cells/well. Then, these cells were fixed in 4% paraformaldehyde/PBS for 15 min. After washing cells with PBS three times, cells were permeabilized with 0.1% Triton X-100/PBS for 20 min. Nonspecific binding was blocked by incubating with Block Ace for 1 h at room temperature. Then, they were treated with primary antibody against UCH-L1 diluted at 1:1,000 at 4°C overnight. After washing three times with PBS, Alexa Fluor 488-labeled goat anti-rabbit IgG antibody diluted at 1:1,000 in PBS was added to these samples for 1 h at room temperature. To visualize the nuclei, To-Pro-3 iodide (Life Technologies, Carlsbad, CA, USA) in PBS at a dilution of 1:1,000 was introduced into these samples together with secondary antibody. After washing with PBS, these samples were immersed with VectaShield (Vector Laboratories Inc., Burlingame, CA, USA) and covered with coverslips. Finally, the stained cells were photographed under a Zeiss LSM 510 confocal microscope.

Semi-quantitative RT-PCR analysis
---------------------------------

Total RNA was isolated from αT3-1 and LβT-2 cells using TRIzol reagent (Life Technologies) according to the manufacturer's protocol. For semi-quantitative RT-PCR, the total RNA was reverse transcribed using Superscript III reverse transcriptase (Life Technologies) with oligo (dT) primers (Life Technologies) according to the manufacturer's instruction. Then, the expressions of mRNA were monitored by RT-PCR. The primer sets used in this experiment are listed in [Table 1](#tbl_001){ref-type="table"}Table 1.Primer sets for semi-quantitative RT-PCRGenesForward primer (5'-3')Reverse primer (5'-3')Length^1)^Mouse *Uchl1*CCGTCCTGAAACAGTTTCTGAGCTGCTTTGCAGAGAGCCA335Mouse *Uchl3*GGAGCCTGAACTTCTTAGCATGGTGGATTAGTCCAATCGTTCCACA195Mouse *Uchl4*GCCTGTGGAACGATTGGAACGATTCCACCACTGCTGGGCTATTCTTGT622Mouse *Uchl5*GGTCCAGGACTCCAGACTTGAACCCTCTCTTAACCCGTCTAGTT348Mouse common-α-subunitGCAGCTGTCATTCTGGTCATGCGACTTGTGGTAGTAGCAAG339Mouse *Fshb*AGCACTGACTGCACCGTGAGCCTCAGCCAGCTTCATCAGC606Mouse *Lhb*GCCTGTCAACGCAACTCTGGCAGGCCATTGGTTGAGTCCT300Mouse *Gapdh*GTCTTCACCACCATGGAGAAACAACCTGGTCCTCAGTGTA545^1)^Length of product after PCR amplification.. RT-PCR was performed under the following conditions: initial denaturation at 94°C for 2 min, followed by gene specific cycles of denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec and elongation at 72°C for 1 min, followed with a final extension at 72°C for 5 min. Data was normalized to expression level of glyceraldehyde-3-phosphate dehydrogenase (*Gapdh*).

Western blot analysis
---------------------

Tissue extracts or cell lysates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 12.5% gel for UCH-L1 protein. After being separated by electrophoresis, proteins were transferred to a polyvinylidene fluoride (PVDF) membrane and blocked with 5% nonfat dry milk in PBS plus 1% Tween 20 (PBST) for 1 h at room temperature. The membranes were incubated with anti-UCH-L1 antibody (1:20,000), anti-UCH-L3 antibody (1:1,000) or anti-β-actin antibody (1:20,000) as an internal control overnight at 4°C. Then, the membranes were subsequently incubated with horseradish peroxidase-conjugated anti-rabbit IgG (1:10,000) or horseradish peroxidase-conjugated anti-mouse IgG (1:10,000) (Vector Laboratories) for 1 h at room temperature. Immunoreactions were visualized by ECL plus (GE Healthcare, Piscataway, NJ, USA) and were detected using a CCD camera system (LAS-4000, Fujifilm, Tokyo, Japan).

Statistical analysis
--------------------

Normalized data on mRNA and protein expressions are shown as the means with standard error of the means (SEM). Statistical analysis was performed with Student's *t*-test for comparisons between groups using Microsoft Excel software. Values of *P*\<0.05 were considered statistically significant.

Results {#s3}
=======

Expression of UCH-L1 in the anterior pituitary gland
----------------------------------------------------

To evaluate the expression level of UCH-L1 protein in the anterior pituitary gland, we performed a Western blot analysis with the anterior pituitary gland and other tissue extracts. The level of UCH-L1 in the anterior pituitary gland was extremely high, even significantly higher than that in the brain ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Western blot analysis of UCH-L1 protein expression in 8-week-old ICR mouse tissues. Various tissues as indicated from 8-week-old ICR mice were lysed and separated on 12.5% SDS-PAGE. β-actin was used as a control.). The UCH-L1 protein was not detected in protein extracts from the spleen, lung, liver as well as kidney. Furthermore, we conducted an immunohistochemical analysis to reveal the expression pattern of UCH-L1 in the pituitary gland ([Fig. 2a](#fig_002){ref-type="fig"}Fig. 2.Immunohistochemical analysis of UCH-L1 protein distribution in 8-week-old ICR mouse pituitary gland. Pituitary glands from 8-week-old ICR mice were sectioned (2 *µ*m thickness) to immunohistochemical analysis. (a) Overall immunoreactivity of UCH-L1 in the pituitary gland, bar=500 *µ*m. (b), (c), (d) and (e) High magnification of each rectangle as marked in (a), anterior lobe (b, c), intermediate lobe (d) and posterior lobe (e). Bar=50 *µ*m.). UCH-L1 immunoreactivity was detected in a large proportion of cells in the anterior lobe. In these cells, immunoreactive UCH-L1 was predominantly located in the nucleus with or without immunoreactive cytoplasm. On the other hand, some cells exhibited UCH-L1 immunoreactivity in the cytoplasm, but not in the nucleus ([Fig. 2b and c](#fig_002){ref-type="fig"}). The cells in the intermediate lobe showed quite weak UCH-L1 immunoreactivity ([Fig. 2d](#fig_002){ref-type="fig"}). In the posterior lobe, which is mainly composed of nerve terminals extended from the hypothalamus, UCH-L1 immunoreactivity was strongly expressed, but not in diffused pituicytes ([Fig. 2e](#fig_002){ref-type="fig"}).

Localization of UCH-L1 protein in the anterior pituitary gland
--------------------------------------------------------------

The anterior lobe of pituitary gland consists of five different types of hormone-producing cells and non-hormone-producing FS cells. In an effort to investigate the cells in which UCH-L1 is expressed, we conducted a double-fluorescent staining to precisely position the localization of UCH-L1 protein in the anterior pituitary gland. As shown in [Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Immunofluorescent analysis of UCH-L1 localization in 8-week-old ICR mouse pituitary gland. Pituitary glands from 8-week-old ICR mice were sectioned (2 *µ*m thickness) to immunofluorescent analysis. Double immunofluorescent staining of UCH-L1 protein (green) with each anterior pituitary hormone or FS cells marker S-100 (red). The immunofluorescence of UCH-L1 (left panels), pituitary hormones or S-100 (intermediate panels), and their merged images (right panels) are presented. TSH (a), ACTH (b), FSH (c), LH (d), GH (e), PRL (f) and S-100 (g). Bar=50 *µ*m., UCH-L1 protein was co-stained with each hormone, respectively, as well as S-100, a marker for FS cells. Generally, UCH-L1 immunoreactivity was observed in the nuclei of six hormone-producing cells. However, the immunoreactivity of UCH-L1 in the cytoplasm showed relatively specific and distinctive pattern. UCH-L1 protein was expressed almost exclusively in the cytoplasm of many FSH-, LH- and PRL-producing cells ([Fig. 3c, d and f](#fig_003){ref-type="fig"}), while not in those of TSH-, ACTH- and GH-producing cells ([Fig. 3a, b, e](#fig_003){ref-type="fig"}). In addition, we did not observe UCH-L1 was co-expressed with FS cell marker S-100, which suggested UCH-L1 protein was not located in the non-hormone-producing cells ([Fig. 3g](#fig_003){ref-type="fig"}).

Patterns of hormone-producing cells were altered in UCH-L1-deficient gad mice
-----------------------------------------------------------------------------

We observed that UCH-L1 protein was exclusively expressed in hormone-producing cells in the anterior pituitary gland and the distribution of UCH-L1 was different among cell types. To assess function of UCH-L1, we compared hormone expression in the anterior pituitary cells between wild type (WT) and UCH-L1-deficient *gad* mice. As expected, the expression of UCH-L1 was not detected in homozygous *gad* mice ([Fig. 4b](#fig_004){ref-type="fig"}Fig. 4.Immunohistochemical analysis of the anterior pituitary gland in wild type and UCH-L1-deficient *gad* mice. Pituitary glands from 8-week-old wild type (a) or *gad* mice (b) were sectioned (2 *µ*m thickness) to immunohistochemical analysis of UCH-L1, bar=50 *µ*m. Immunohistochemistry of FSH (c, d), LH (e, f), PRL (g, h) and GH (i, j) in the anterior pituitary glands of 22-week-old wild type (c, e, g and i) or *gad* mice (d, f, h and j), Bar=50 *µ*m.). Immunohistochemical analyses were conducted with anti-FSH, LH, PRL and GH antibodies. A lot of GH-expressing cells were observed in the anterior pituitary glands and comparable in WT and *gad* mice ([Fig. 4i and j](#fig_004){ref-type="fig"}). Although a modest number of FSH-, LH- and PRL-expressing cells were observed in WT mice ([Fig. 4c, e and g](#fig_004){ref-type="fig"}), to our surprise, obviously decreased number of FSH-, LH- and PRL-expressing cells were observed in *gad* mice compared to those in WT mice ([Fig. 4d, f and h](#fig_004){ref-type="fig"}).

Expressions of UCH-L1 and other UCHs in gonadotrope cell lines
--------------------------------------------------------------

The data from *gad* mice suggested that UCH-L1 play an important role in FSH-, LH- and PRL-expressing cells. So, we examined also whether gonadotropes express UCH-L1 or not using gonadotrophic cultured cell lines αT3-1 and LβT-2 \[[@r1], [@r24]\]. aT3-1 and LβT-2 cells have been considered immature and mature types of gonadotropes, respectively \[[@r5], [@r24]\], which was supported by our data that LβT-2 cells only expressed *Fshb* and *Lhb* subunits gene in accordance with previous studies ([Fig. 5](#fig_005){ref-type="fig"}Fig. 5.Confirmation on expressions of three subunits of gonadotropin genes in αT3-1 and LβT-2 cells. The total RNA was extracted and reverse transcribed from both cell lines, and RT-PCR analysis was performed using specific primers for each mouse gene as listed in [Table 1](#tbl_001){ref-type="table"}. Left and right three lanes except both ends represent the expressions of three subunits of gonadotropin genes in αT3-1 and those in LβT-2 cells, respectively. DNA size markers are shown in both ends.). We examined both mRNA and protein expression levels of UCH-L1 in these two cell lines. The mRNA expression of *Uchl1* in αT3-1 cells was much higher than that in LβT-2 cells, with a statistical significance (*P*\<0.05, [Fig. 6A](#fig_006){ref-type="fig"}Fig. 6.The expressions of UCH-L1 and other UCHs in αT3-1 and LβT-2 cells. A: Semi-quantitative RT-PCR analyses of *Uchl1* and other UCH isozymes in αT3-1 and LβT-2 cells. The total RNA was extracted from these cells, and RT-PCR analysis was performed using specific primers as listed in [Table 1](#tbl_001){ref-type="table"}. The graphs represent the averaged band intensities of UCHs with SEM, normalized with *Gapdh*. Statistical analysis was conducted using Student's *t*-test (\**P*\<0.05). B: Protein expression of UCH-L1 and UCH-L3 in αT3-1 and LβT-2 cells. αT3-1 and LβT-2 cell lysates were examined by Western blot on 12.5% gel. β-actin was used as a control. The graphs represent the averaged band intensities of UCH-L1 and UCH-L3 with SEM, normalized with β-actin. Statistical analysis was conducted using Student's *t*-test.). However, this difference was not seen in the protein levels ([Fig. 6B](#fig_006){ref-type="fig"}). Furthermore, semi-quantitative RT-PCR analyses of other UCH isozymes were also performed in these two cell lines. Although the expression levels of *Uchl4* and *Uchl5* were almost comparable between two cell lines, expression level of *Uchl3* in LβT-2 cells was significantly higher than that in aT3-1 cells, approximately 2.4-fold ([Fig. 6A](#fig_006){ref-type="fig"}). However, the difference was not observed by Western blot analyses, in which the expression level of UCH-L3 protein was almost the same between two cell lines ([Fig. 6B](#fig_006){ref-type="fig"}). Subsequently, we examined the distribution of UCH-L1 in these cell lines. As shown in [Fig. 7](#fig_007){ref-type="fig"}Fig. 7.The localization of UCH-L1 protein in αT3-1 and LβT-2 cells. To examine the localization of UCH-L1 protein in αT3-1 (upper panels) and LβT-2 cells (lower panels), immunofluorescent staining of UCH-L1 was conducted. TO-PRO-3 was used to visualize the nuclei (a, e). UCH-L1 (b, f), the merged (c, g) and transparent images (d, h) are presented. Images were photographed using a Zeiss LSM 510 confocal microscope., the localization of UCH-L1 exhibited a similar pattern between αT3-1 and LβT-2 cells, in which UCH-L1 was expressed throughout the whole cells, with bright fluorescence in the cytoplasm and a fractionally weak fluorescence in the nucleus.

Discussion {#s4}
==========

The ubiquitin-mediated protein degradation pathway is essential for eukaryotes and modulates many cellular processes \[[@r6]\]. The proteins which are targeted for proteolysis are labeled with polyubiquitin chains and eventually degraded by the 26S proteasome \[[@r30]\]. After degradation of target proteins, DUBs regenerate polyubiquitin chains into individual ubiquitin molecules in order that they can be used again in the subsequent rounds. UCH-L1, a member of DUBs, is selectively and abundantly expressed in neurons and germ cells \[[@r13], [@r29], [@r34]\]. The HPG-axis is composed of three separate components which interact together to fulfill their assignments and are crucial to reproduction. Previous studies on UCH-L1 have mainly and intensively focused on its roles in neurons and genital organs of both sexes \[[@r14], [@r16], [@r26], [@r38], [@r39]\]. However, the expression and the role of UCH-L1 in the pituitary gland have remained largely unknown. Although the anterior pituitary gland is an extremely small tissue in the body, it plays crucial roles in the endocrine system. Distinct hormone-producing cells cluster in the anterior lobe and regulate each of their downstream targets \[[@r2]\]. In the present study, we firstly confirmed the expression of UCH-L1 by Western blot analysis. UCH-L1 has been reported to be a key protein in the brain, not only its diverse functions, but also its abundance, accounting for approximate 1--2% of total proteins \[[@r32], [@r34]\]. Surprisingly, an extremely high expression level of UCH-L1 was detected in the anterior pituitary gland than that of brain extracts, which suggests the importance of UCH-L1 in the anterior pituitary glands. By immunohistochemistry, we have shown that the majority of the anterior pituitary cells was immuno-positive for UCH-L1. However, it is hard to determine the types of cells expressing UCH-L1 by special location or cell shapes such as spermatocyte in the testis, or one-cell oocyte in the ovary. Here, we conducted immunofluorescent analyses to investigate the cell types in which UCH-L1 was expressed.

FS cells belong to a non-hormone producing cell type in the anterior pituitary gland \[[@r9], [@r10]\]. Except FS cells, UCH-L1 immunoreactivity was detected in the nuclei of all types of hormone-producing cells, and the expression of UCH-L1 in the cytoplasm was seen to be specific to FSH-, LH- and PRL-producing cells. These results suggest that UCH-L1 is involved in the hormone production or development and/or proliferation of FSH-, LH-, and PRL-producing cells.

*gad* mice are an autosomal recessive spontaneous mutant which is characterized with a "dying-back" type of axonal degeneration of the gracile tract \[[@r37]\]. Subsequent analysis revealed an intragenic deletion of *Uchl1* gene in this strain. Since *gad* mice do not express UCH-L1, they are considered as UCH-L1 null mutant mice \[[@r25]\]. Our previous studies have demonstrated that the lack of UCH-L1 resulted in an increase in abnormal spermatozoa, and a significantly increased rate of polyspermy in oocytes, respectively \[[@r18], [@r27]\]. Furthermore, overexpression of UCH-L1 caused the inhibition of spermatogenesis, eventually leading to male infertility \[[@r31]\]. These results suggest that the appropriate expression of UCH-L1 is essential for reproduction. The anterior pituitary gland is an upstream tissue regulating terminal sexual organs. Alterations in the anterior pituitary gland would affect its regulation on the downstream tissues, which includes the testis and ovary. In the present study, we have shown significant decreases in FSH- and LH-expressing cell numbers in *gad* mice, which might contribute to the defect in reproduction in *gad* mice \[[@r36]\].

We detected that the expression of UCH-L1 was in the nuclei of all six types of hormone-producing cells. However, cytoplasmic expression of UCH-L1 was only found in FSH-, LH- and PRL-producing cells. Subsequent analysis on *gad* mice revealed significant decrease in numbers of the cytoplasmic UCH-L1 expressing cells. We could not explain whether the specific expression of UCH-L1 was involved in the maintenance of these cells, and further study is needed to elucidate this issue. UCH-L1 is believed to hydrolyze the bonds between ubiquitin and small adducts *in vitro*, and the hydrolase activity of UCH-L1 is significantly lower than its isozyme UCH-L3 \[[@r19]\]. However, substrate(s) of this enzyme *in vivo* has not yet been identified. It is also necessary to be resolved whether some unknown substrates in the cytoplasm are linked with decreases in FSH-, LH- and PRL-producing cells in *gad* mice. In addition, a recently released report demonstrated that UCH-L1 functioned as a potentiator of cyclin-dependent kinases (CDKs) to enhance cell proliferation \[[@r11]\]. However, the enhancement of UCH-L1 was dependent on interaction between UCH-L1 and CDKs, but not on its hydrolase activity. This also urges us to figure out how UCH-L1 functions in the anterior pituitary cells.

Gonadotropes synthesize and secrete FSH and LH, which are critical to both testis and ovary. We have a special interest in the effect of UCH-L1 on these cells. However, the pituitary gland of mice is small and this type of cells constitute approximately 10% of the anterior pituitary cell populations \[[@r8], [@r38]\]. It is not so easy to examine the role of UCH-L1 in gonadotropes in the pituitary gland. As an alternative approach, αT3-1 and LβT-2 cells, two immortalized cell lines established from the pituitary glands, were examined \[[@r1], [@r35]\]. UCH-L1 was found to be expressed in both nuclei and cytoplasm in these cell lines, which was consistent with our results *in vivo*. There are two hypotheses for the decrease in the number of gonadotropes in the pituitary gland of *gad* mice: 1) decrease in cell numbers by apoptosis; 2) failure to synthesize FSH or LH. αT3-1 cells are considered to represent immature type of gonadotropes and do not express β-subunits of gonadotropin. We detected a relatively comparable level of UCH-L1 in αT3-1 cells to that of LβT-2 cells, which might exclude a direct relevance between UCH-L1 and β-subunit expressions. However, some reports pointed out that the failure of synthesizing hormones in αT3-1 cells might be in part due to transcriptional suppressions \[[@r20]\]. Anyway, LβT-2 cells would be a useful model to study the function of UCH-L1 in gonadotropes and provide us an opportunity to examine the role of UCH-L1 in hormone production in gonadotropes using UCH-L1-specific inhibitor or RNAi technique in the future. In addition, we could examine whether UCH-L1 colocalized with FSH or LH in gonadotrope cell lines after GnRH stimulation as in mice ([Fig. 3](#fig_003){ref-type="fig"}).

UCH-L1 and UCH-L3 are two predominant isozymes in mammals. These two isozymes are believed to have overlapping and reciprocal functions. Relative to *gad* mice, UCH-L1/UCH-L3 double knockout mice display a more severe axonal and cell body degeneration of the gracile tract \[[@r15]\]. On the other hand, UCH-L1 is considered as a pro-apoptotic regulator, while UCH-L3 is thought to be anti-apoptotic in a cryptorchid injury in the testis \[[@r17]\]. Furthermore, our previous study revealed that UCH-L1 and UCH-L3 might play distinct roles in spermatogenesis, in which UCH-L1 was mainly expressed in spermatogonia, while the expression of UCH-L3 was predominantly detected in spermatocytes and spermatids \[[@r16]\]. As mentioned above, αT3-1 and LβT-2 cells are considered to represent immature and mature types of gonadotropes. In the present study, we have shown distinct mRNA expressions of *Uchl1* and *Uchl3* in these cell lines, although the protein expression levels of these two isozymes did not show a significant difference. This might reflect their different requirements during development of gonadotropes.

In conclusion, we demonstrated the specific localization of UCH-L1 in mouse anterior pituitary gland for the first time and provided evidence that UCH-L1 might be involved in hormone production or development and/or proliferation of FSH-, LH-, and PRL-producing cells.
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